the united republic of tanzania health sector hiv and aids strategic plan
the united republic of tanzania health sector hiv and aids strategic plan
the united republic of tanzania health sector hiv and aids strategic plan
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Strategic Objectives 3: To streng<strong>the</strong>n <strong>and</strong> sustain HIV drug resistance activities, STI drug resistance monitoring <strong>and</strong> pharmacovigilance <strong>of</strong> HIV drugs<br />
Strategy 1: Conduct STI drug <strong>and</strong> TB drug susceptibility monitoring<br />
Activities Targets Indicators Means <strong>of</strong><br />
Establish monitoring <strong>of</strong> ARV resistance in<br />
two referral labs<br />
Streng<strong>the</strong>n <strong>and</strong> develop capacity for<br />
monitoring <strong>of</strong> Anti TB resistance in HIV<br />
infected persons in one referral <strong>and</strong><br />
Kibong’oto lab<br />
Establish monitoring <strong>of</strong> antimicrobial<br />
resistance <strong>of</strong> STIs in 5 referral labs<br />
Streng<strong>the</strong>n capability <strong>of</strong> laboratories to<br />
make diagnosis <strong>of</strong> STI drugs resistance<br />
Build capacity <strong>of</strong> <strong>the</strong> National & Zonal<br />
hospital to diagnosis HIV resistance to<br />
ARVs<br />
Train <strong>health</strong> care workers on diagnosis <strong>of</strong><br />
STI <strong>and</strong> ARV drugs resistance<br />
Two referral lab monitoring<br />
for ARV resistance<br />
One referral lab <strong>and</strong><br />
Kibong’oto hospital perform<br />
TB cultures <strong>and</strong> monitor<br />
anti-Tb resistance<br />
Five referral labs monitoring<br />
antimicrobial resistance <strong>of</strong><br />
STIs<br />
National <strong>and</strong> zonal hospital<br />
able to identify STI drug<br />
resistance<br />
National <strong>and</strong> zonal hospital<br />
able to detect HIV resistance<br />
to ARV <strong>the</strong>rapy<br />
109 |FINAL COMBINED-HSHSP 2008-2012: June 24 th 2007<br />
No. <strong>of</strong> referral lab with<br />
established monitoring<br />
for ARV resistance<br />
No. <strong>of</strong> designated<br />
laboratories performing<br />
TB cultures <strong>and</strong><br />
sensitivity testing<br />
No <strong>of</strong> referral labs with<br />
established monitoring <strong>of</strong><br />
antimicrobial resistance<br />
<strong>of</strong> STIs<br />
Health care workers are<br />
able to diagnosis ARVs<br />
resistance<br />
verification<br />
Reports MOHSW<br />
PORALG<br />
Health<br />
facilities<br />
Key actor Partners Resources Remarks<br />
Strategy 2: Streng<strong>the</strong>n a mechanism for tracking <strong>and</strong> providing feedback on ADR associated with HIV <strong>and</strong> AIDS, STI <strong>and</strong> OIs medication.<br />
Activities Targets Indicators Means <strong>of</strong> Key actor Partners or Resources Remarks<br />
verification<br />
collaborators<br />
ADR monitoring forms to be available at ADR monitoring forms Proportion <strong>of</strong> HFs with Reports TFDA<br />
HFs levels<br />
available at HF levels ADR forms<br />
Train HW to recognize <strong>and</strong> report all ADR HW sensitized to recognize Proportion <strong>of</strong> HWs sable<br />
related to HIV/AIDS, STIs <strong>and</strong> OIs <strong>and</strong> report all ADRs related to recognize ADR related<br />
medication.<br />
to HIV/AIDS, STIs <strong>and</strong> OIs to HIV/AIDS, STIs <strong>and</strong><br />
medication.<br />
OIs medication.<br />
Form a national committee on ADR for National committee on ADR List <strong>of</strong> national committee<br />
HIV/AIDS, STIs <strong>and</strong> OIs medicines. for HIV/AIDS, STIs <strong>and</strong> OIs members on ADR for<br />
medicines formed.<br />
HIV/AIDS, STIs <strong>and</strong> OIs<br />
medicines.
Change language